Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering.

The Cell and Gene Therapy Business Outlook includes market sizing and forecasting of CAGT Markets. It sizes up the market opportunity and projects the future revenues for a given therapeutic segment.

With billions of investment dollars announced each year, the Cell and Gene Therapy Business Outlook tracks who is getting financed (and the companies behind the financing) each issue. It analyzes trends in that financing.

The Cell and Gene Therapy Business Outlook is designed to provide the most relevant news. With a focus on what the recent news of the day means for business, the curated news and news analysis means that you and your organization can be confident you won't miss an important development in cell and gene therapy.

Each issue's "Recent Deals Table" tracks the important deals between stem cell companies as well as the deals they engage in (tech transfers, partnerships, mergers, distribution and other activities) with companies outside the industry.

This newsletter will also report on developments, product launches and deals relating to the makers of cell and gene therapy manufacturing equipment and supplies.

For more information about this report visit https://www.researchandmarkets.com/r/yia60e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900